» Articles » PMID: 29077210

Hepatocyte DUSP14 Maintains Metabolic Homeostasis and Suppresses Inflammation in the Liver

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2017 Oct 28
PMID 29077210
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Conclusion: Hepatocyte DUSP14 is required for maintaining hepatic metabolic homeostasis and for suppressing inflammation, a novel function that relies on constraining TAK1 hyperactivation. (Hepatology 2018;67:1320-1338).

Citing Articles

Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases.

Wang A, Zhang Y, Lv X, Liang G Acta Pharm Sin B. 2024; 14(8):3295-3311.

PMID: 39220870 PMC: 11365412. DOI: 10.1016/j.apsb.2024.05.006.


Inhibiting TRIM8 alleviates adipocyte inflammation and insulin resistance by regulating the DUSP14/MAPKs pathway.

Zhu M, Pu J, Zhang T, Shao H, Su R, Tang C Adipocyte. 2024; 13(1):2381262.

PMID: 39039652 PMC: 11268219. DOI: 10.1080/21623945.2024.2381262.


USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1.

Tang M, Cao H, Ma Y, Yao S, Wei X, Tan Y J Transl Med. 2024; 22(1):671.

PMID: 39033101 PMC: 11264885. DOI: 10.1186/s12967-024-05465-4.


Myeloid-derived growth factor in diseases: structure, function and mechanisms.

Chen P, Huang X, Li W, Wen W, Cao Y, Li J Mol Med. 2024; 30(1):103.

PMID: 39030488 PMC: 11264862. DOI: 10.1186/s10020-024-00874-z.


Targeting Protein Phosphatases for the Treatment of Chronic Liver Disease.

Li Y, He H, Zhang N Curr Drug Targets. 2024; 25(3):171-189.

PMID: 38213163 DOI: 10.2174/0113894501278886231221092522.